Shanghai Xinyi Baileda Pharmaceutical

Shanghai Xinyi Baileda Pharmaceutical is a specialized pharmaceutical company based in China, operating as a subsidiary of the Shanghai Pharmaceuticals Holding group. The company is primarily recognized for its expertise in the development and manufacturing of botanical-based medicines, specifically focusing on Ginkgo biloba extract (EGb761) preparations. Its flagship product, marketed under the brand name Baileda, is widely used for treating cardiovascular and cerebrovascular conditions, including cognitive impairment and peripheral circulatory disorders. The company maintains high-standard manufacturing facilities and contributes to the modernization of traditional herbal medicine through rigorous extraction and quality control processes.